help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsueh, W. A.
Right arrow Articles by Warren, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsueh, W. A.
Right arrow Articles by Warren, S.

Journal of Clinical Endocrinology & Metabolism, Vol 51, 942-944, Copyright © 1980 by Endocrine Society


ARTICLES

Renin requires a structural alteration prior to activation by renal kallikrein

WA Hsueh, EJ Carlson, D O'Connor and S Warren

Renal kallikrein may be the physiologic protease which activates renin. In vitro activation of plasma inactive renin by renal kallikrein, however, requires prior dialysis of plasma to pH 3.3, which is thought to destroy endogenous plasma kallikrein inhibitors. We present evidence that low pH directly alters renin to facilitate its activation by renal kallikrein. Untreated normal plasma was combined with pH 3.3 dialyzed and neutralized plasma and incubated with semipurified human renal kallikrein 2.3 X 10(-2) to 4.6 IU/ml, pH 7.5, 25 degrees C for 1h. All concentrations activated renin in acid-treated plasma; whereas, in untreated plasma 4.6 IU/ml renal kallikrein was ineffective. In combinations of untreated and acid-treated plasma, the percent renin activated by renal kallikrein was equal to the percent acid-dialyzed plasma present. When acid-treated plasma was combined with buffer, activation was complete and quantitatively the same as in the untreated and acid-treated plasma combinations. The data suggest inactive renin itself is altered structurally by pH 3.3; this change in the renin molecule is necessary for kallikrein activation. Renal kallikrein may not be the sole in vivo activator of renin.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society